Paper20128070
Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T and 5 others. J Med Assoc Thai, 2009. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis. Papers, record 20128070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20128070
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Cardiovascular Diseases | Major topic |
| Cyclooxygenase 2 Inhibitors | Major topic |
| Gastrointestinal Diseases | Major topic |
| Osteoarthritis, Knee | Major topic |
| Age Factors | |
| Aged | |
| Aged, 80 and over | |
| Cohort Studies | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Risk | |
| Sex Factors | |
| Time Factors |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02593721 | Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment | Results | ClinicalTrials.gov | |
| NCT02595294 | Hypoalgesic Effect of Neural Mobilization | Results | ClinicalTrials.gov | |
| NCT02596815 | Hypoalgesic Effect of Median Nerve Neural Mobilization Compared to a Controlled Group | Background | ClinicalTrials.gov |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42014647 | Clinical efficacy and mechanisms of krill oil supplementation in knee osteoarthritis: meta-analysis and mechanistic insights. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42014647 | PubMed |
| 35329224 | Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35329224 | PubMed |
| 34833894 | Preclinical Pharmacokinetics and Acute Toxicity in Rats of 5-{[(2E)-3-Bromo-3-carboxyprop-2-enoyl]amino}-2-hydroxybenzoic Acid: A Novel 5-Aminosalicylic Acid Derivative with Potent Anti-Inflammatory Activity. | Molecules | 2021 | https://conductscience.org/library/papers/34833894 | PubMed |
| 30650407 | Probable Etoricoxib-Induced Severe Thrombocytopenia: A Case Report. | Med Princ Pract | 2019 | https://conductscience.org/library/papers/30650407 | PubMed |
| 29551098 | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. | Prim Health Care Res Dev | 2018 | https://conductscience.org/library/papers/29551098 | PubMed |
| 27473713 | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand. | Int J Clin Pharm | 2016 | https://conductscience.org/library/papers/27473713 | PubMed |
| 25985838 | Clopidogrel versus aspirin in patients with recent ischemic stroke and established peripheral artery disease: an economic evaluation in a Chinese setting. | Clin Drug Investig | 2015 | https://conductscience.org/library/papers/25985838 | PubMed |
| 25288144 | Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. | Int J Clin Pharm | 2014 | https://conductscience.org/library/papers/25288144 | PubMed |
| 24693375 | Epidemiological investigation of osteoarthritis in middle-aged mongolian and senior residents of the inner mongolia autonomous region. | Iran Red Crescent Med J | 2013 | https://conductscience.org/library/papers/24693375 | PubMed |
| 24672232 | Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. | Clin Interv Aging | 2014 | https://conductscience.org/library/papers/24672232 | PubMed |
| 24549233 | Antiplatelet and antithrombotic activities of non-steroidal anti-inflammatory drugs containing an N-acyl hydrazone subunit. | Molecules | 2014 | https://conductscience.org/library/papers/24549233 | PubMed |
| 22843164 | Molecular mechanisms elucidating why old stomach is more vulnerable to indomethacin-induced damage than young stomach. | Dig Dis Sci | 2013 | https://conductscience.org/library/papers/22843164 | PubMed |
| 22559274 | Evolution of topical NSAIDs in the guidelines for treatment of osteoarthritis in elderly patients. | Drugs Aging | 2012 | https://conductscience.org/library/papers/22559274 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| IBUPROFEN | CHEMBL521 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL521 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20128070
GET https://conductscience.org/api/papers/v1/20128070/authors